title: [Long-acting beta-2-adrenergic agonists in bronchospasm therapy].
abstract: Inhaled long-acting beta 2-agonists are widley used in the treatment of asthma as regular prophylaxis, but not as rescue medication for the relief of acute symptoms. Comparison of salmeterol and formoterol in the review is focused on practical applications and some adverse reactions during long-time treatment.
authors.affiliation: Klinika Chorób Wewnetrznych, Pneumonologii i Alergologii IMW CSK WAM w Warszawie.
authors.forename: T
authors.initials: T
authors.lastname: Płusa
mesh_terms: D000318:Adrenergic beta-Agonists / Q000494:pharmacology* / Q000627:therapeutic use; D000420:Albuterol / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D001986:Bronchial Spasm / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D004983:Ethanolamines / Q000494:pharmacology* / Q000627:therapeutic use; D000068759:Formoterol Fumarate; D006801:Humans; D018343:Receptors, Adrenergic, beta-2 / Q000187:drug effects*; D000068299:Salmeterol Xinafoate
chemical_list: D000318:Adrenergic beta-Agonists; D003692:Delayed-Action Preparations; D004983:Ethanolamines; D018343:Receptors, Adrenergic, beta-2; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D000068759:Formoterol Fumarate
vernacular_title: Agoniści receptorów beta 2-adrenergicznych o przedłuzonym działaniu w leczeniu stanów bronchospastycznych.